Drawing for NEOGENOMICS NEOANTIGEN DISCOVERY

USPTO serial 87679966

NEOGENOMICS NEOANTIGEN DISCOVERY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
BELLO, ZACK
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NEOGENOMICS NEOANTIGEN DISCOVERY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Pre-packaged medical tests kits and medical test kits to aid in the diagnosis of disease or cancer, namely, kits primarily composed of DNA probes and also containing clinical medical reagents and antibodies for use in disease testing for clinical medical laboratory useACTIVE
005Medical tests kits primarily comprised of medical diagnostic reagents and assays for testing body fluidsACTIVE
009Downloadable webinars in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; downloadable electronic publications in the nature of newsletters and abstracts in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; software for medical testing and analysis of medical test results; software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; computer software to acquire, capture, extract, except, analyze, organize, and manage medical testing, biological information, medical tests, medical test data, and medical test results for the processing of test data and for analysis of medical test results; computer software for enhancing the analysis of research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to testing and analysisACTIVE
042Medical and scientific research information in the field of human disease and human medical conditions; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing in the field of human disease and human medical conditions; clinical laboratory services, oncology reference laboratory services; providing information, interactive information, and reports to others in the field of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions; providing information to others in the field of scientific testing and research and clinical scientific testing; providing an internet website portal featuring information in the field of scientific testing and research, medical research, and clinical scientific testing; providing cloud-based information to others in the field of scientific testing and research, medical research, and clinical scientific testing; providing online non-downloadable Internet-based software for medical testing and analysis of medical test results; providing online non-downloadable Internet-based software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; software as a service (SAAS) services featuring software for medical testing and analysis of medical test results; Software as a service (SAAS) services featuring software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; genetic mapping for scientific purposes, namely, gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells; scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, and cancerACTIVE
044Medical information; medical diagnostic testing services in the field of human disease and human medical conditions; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposes; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing, and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, human medical conditions, medical diagnostic testing, medical testing for diagnostic or treatment purposes, and the delivery of scientific and medical test results; providing cloud-based medical information to others in the field of human disease, human medical conditions, medical diagnostic testing, and medical testing for diagnostic or treatment purposesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 18, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 18, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 13, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 12, 2019EX3GSOU EXTENSION 3 GRANTED
Sep 12, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 9, 2019EXT3SOU EXTENSION 3 FILED
Sep 9, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 3, 2019ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 27, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 25, 2019EX2GSOU EXTENSION 2 GRANTED
Feb 25, 2019EXT2SOU EXTENSION 2 FILED
Feb 25, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 7, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 5, 2018EX1GSOU EXTENSION 1 GRANTED
Sep 5, 2018EXT1SOU EXTENSION 1 FILED
Sep 5, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 13, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 16, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 16, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 27, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 6, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 29, 2017DOCKASSIGNED TO EXAMINER
Nov 21, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 14, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance